RBK EMD Co., Ltd. (KOSDAQ:A106080) agreed to acquire 6.49% stake in Mirae SCI Co., Ltd. (KOSDAQ:A028040) from Citrus Consulting Co., Ltd, Asan Sangjo Co. Ltd and Tryus R C Co., ltd for KRW 10 billion on October 10, 2018. Under the terms, RBK EMD will acquire 2 million shares of Mirae SCI at KRW 5000 per share in cash. The transaction has been resolved by the Board of Directors of RBK EMD Co., Ltd at the meeting held on October 10, 2018. The transaction is expected to be completed by October 12, 2018. Changhae Accounting Corporation acted as external rating institution in a transaction.

RBK EMD Co., Ltd. (KOSDAQ:A106080) completed the acquisition of 6.49% stake in Mirae SCI Co., Ltd. (KOSDAQ:A028040) from Citrus Consulting Co., Ltd, Asan Sangjo Co. Ltd and Tryus R C Co., ltd on October 11, 2018. Under the terms, Citrus Consulting Co., Ltd. sold 1.2 million shares and reduced the shareholding from 2.2 million shares to 0.95 million shares in Mirae SCI. As of December 17, 2018, the remaining balance payment is in default and still in discussions.